Zephyr Health is a technology company.
Zephyr Health has raised $32.0M across 2 funding rounds.
Zephyr Health has raised $32.0M in total across 2 funding rounds.
Zephyr Health has raised $32.0M in total across 2 funding rounds.
Zephyr Health's investors include Byers Capital, Domain Associates, Fifth Wall, Kleiner Perkins, Merus Capital, Practical Venture Capital, Streamlined Ventures, Susa Ventures, TSVC Capital, Versant Ventures, Adam Jackson, Don Hutchison.
Zephyr Health is a technology company founded in 2011 that built an insights-as-a-service platform called Zephyr Illuminate, aggregating and linking disparate healthcare data sources—including CRM, sales, vendor, public global data, physicians, institutions, and treatments—for life sciences companies.[1][5][6][7] It serves pharmaceutical, biotech, medical device, and diagnostics firms by solving the challenge of coordinating exploding healthcare data (growing 48% year-on-year) to enable faster, data-driven decisions like targeting physicians, advancing therapies, and matching treatments to patients.[1][4][7] The platform accelerates product lifecycles from pre-launch to maturity, providing predictive customer profiles, market insights, and competitor analysis, with the company raising $32.5M before its acquisition by Anju Software in October 2018.[5][6]
Zephyr Health was founded in 2011 in San Francisco by William King, who serves as Founder and Executive Chairman, driven by his personal experience as a patient, father, and caregiver recognizing data's role in healthcare efficiencies.[1][5][6] The idea emerged at the intersection of life sciences and technology, addressing the disconnection of rapidly growing healthcare data to better connect therapies with patients worldwide.[1] Backed by investors like Kleiner Perkins Caufield & Byers, Icon Ventures, and Google Ventures, it gained early traction as a cloud-based platform linking public domain data to enterprise sources for precise stakeholder targeting.[5][6][7] A pivotal moment came with its 2018 acquisition by Anju Software, integrating its proprietary algorithms into a broader life sciences platform to enhance research efficacy and speed therapies to market.[6]
Zephyr Health rides the explosive growth of healthcare data (48% YoY) and the shift toward AI-driven precision medicine in life sciences, where disconnected data hinders therapy development and patient outcomes.[1][3] Its timing aligned with the rise of big data analytics in pharma, enabling faster market entry amid pressures for efficiency in clinical, medical affairs, and commercial operations—key as digital health and AI sectors boomed (e.g., CB Insights tracks 11K+ digital health and 9K+ AI items).[5] By bridging public and proprietary data, it influences the ecosystem through Anju's platform, empowering pharma/biotech to leverage "molecule-to-retirement" insights, reduce R&D timelines, and compete in a market favoring integrated, predictive tools over siloed analytics.[6]
Post-2018 acquisition, Zephyr Health's tech endures within Anju Software, likely evolving with AI advancements to further mine life sciences data for drug discovery and telehealth integration.[3][6] Trends like real-world evidence, multimodal data fusion, and regulatory pushes for faster approvals will amplify its impact, potentially expanding to diagnostics and global telehealth as healthcare data volumes surge.[1][2] Its legacy of turning data chaos into patient wins positions Anju—and by extension, Zephyr's innovations—for deeper ecosystem influence, accelerating therapies in an era where precision insights define competitive edges.[1][7] This data coordination mission, born from a founder's patient perspective, remains a cornerstone for life sciences' data-driven future.[1]
Zephyr Health has raised $32.0M across 2 funding rounds. Most recently, it raised $17.0M Series C in August 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2015 | $17.0M Series C | Byers Capital, Domain Associates, Fifth Wall, Kleiner Perkins, Merus Capital, Practical Venture Capital, Streamlined Ventures, Susa Ventures, TSVC Capital, Versant Ventures, Adam Jackson, Don Hutchison, rich simoni | |
| Jan 1, 2014 | $15.0M Series B | Domain Associates, Kleiner Perkins, Susa Ventures, Versant Ventures |